LB Pharmaceuticals Inc (LBRX)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20267 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to LB Pharmaceuticals Inc’s names, not what it holds today.
9 published
1 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Aug 13, 2024 | 12,060,327 | Psychotropic agents and uses thereof | Pharmaceuticals | LB PHARMACEUTICALS INC. |
| Aug 1, 2023 | 11,713,295 | Psychotropic agents and uses thereof | Pharmaceuticals | LB PHARMACEUTICALS INC. |
| Jul 5, 2022 | 11,377,421 | Psychotropic agents and uses thereof | Pharmaceuticals | LB PHARMACEUTICALS INC. |
| Jun 22, 2021 | 11,040,943 | Psychotropic agents and uses thereof | Pharmaceuticals | LB PHARMACEUTICALS INC. |
| Jun 23, 2020 | 10,689,338 | Psychotropic agents and uses thereof | Pharmaceuticals | LB PHARMACEUTICALS INC. |
| Apr 16, 2019 | 10,259,786 | Psychotropic agents and uses thereof | Pharmaceuticals | LB PHARMACEUTICALS INC. |
| Jan 1, 2019 | 10,167,256 | Psychotrophic agents and uses thereof | Pharmaceuticals | LB PHARMACEUTICALS INC. |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| May 16, 2024 | 2024/0158347 | PSYCHOTROPIC AGENTS AND USES THEREOF | Pharmaceuticals | LB PHARMACEUTICALS INC. |
| May 9, 2024 | 2024/0150283 | PSYCHOTROPIC AGENTS AND USES THEREOF | Pharmaceuticals | LB PHARMACEUTICALS INC. · patent 12,060,327 granted from it |
| Apr 11, 2024 | 2024/0115547 | PSYCHOTROPIC AGENTS AND USES THEREOF | Pharmaceuticals | LB PHARMACEUTICALS INC. |
| May 12, 2022 | 2022/0144770 | PSYCHOTROPIC AGENTS AND USES THEREOF | Pharmaceuticals | LB PHARMACEUTICALS INC. · patent 11,713,295 granted from it |
| Apr 23, 2020 | 2020/0123102 | PSYCHOTROPIC AGENTS AND USES THEREOF | Pharmaceuticals | LB PHARMACEUTICALS INC. · patent 11,377,421 granted from it |
| Mar 12, 2020 | 2020/0079734 | PSYCHOTROPIC AGENTS AND USES THEREOF | Pharmaceuticals | LB PHARMACEUTICALS INC. |
| Feb 20, 2020 | 2020/0055818 | PSYCHOTROPIC AGENTS AND USES THEREOF | Pharmaceuticals | LB PHARMACEUTICALS INC. · patent 10,689,338 granted from it |
| Jan 2, 2020 | 2020/0002277 | PSYCHOTROPIC AGENTS AND USES THEREOF | Pharmaceuticals | LB PHARMACEUTICALS INC. · patent 11,040,943 granted from it |
| Jun 21, 2018 | 2018/0170868 | PSYCHOTROPIC AGENTS AND USES THEREOF | Pharmaceuticals | LB PHARMACEUTICALS INC. · patent 10,167,256 granted from it |
| Jun 7, 2018 | 2018/0155282 | PSYCHOTROPIC AGENTS AND USES THEREOF | Pharmaceuticals | LB PHARMACEUTICALS INC. · patent 10,259,786 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.